Luminist Capital’s BlackRock Health Sciences Trust BME Stock Holding History

Luminist Capital’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.65K	Buy	+60	New	+$2.65K	﹤0.01%	309

Other funds holding BME

Nova R Wealth Overland Park, Kansas $341M AUM 12.71% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.42B AUM 19.31% 1-Year Est. Return

NFP Retirement Inc Aliso Viejo, California $1.88B AUM 9.68% 1-Year Est. Return

Cornerstone Advisory Hunt Valley, Maryland $1.29B AUM 13.16% 1-Year Est. Return

Cypress Capital Management (Wyoming) Sheridan, Wyoming $126M AUM 27.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Luminist Capital's BME Position: Q3 2026 in Review

Luminist Capital opened a new position in BlackRock Health Sciences Trust (BME) in Q3 2026: 60 shares worth $2.65K. The stake represents ﹤0.01% of the portfolio and ranks #309 among its holdings.

65 funds tracked by Wall St. Rank hold BME as of Q3 2026.

Luminist Capital held 60 shares of BlackRock Health Sciences Trust worth $2.65K as of Q3 2026.
BlackRock Health Sciences Trust was a new Luminist Capital position in Q3 2026.
BlackRock Health Sciences Trust made up ﹤0.01% of Luminist Capital's portfolio in Q3 2026, its #309 holding.
65 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2026.

Based on Luminist Capital's 13F filing for Q3 2026, filed 10 Nov 2026.